NCT00800501 - A Safety and Tolerability Study of Intracerebroventricular Administration of sNN0029 to Patients With Amyotrophic Lateral Sclerosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG

sNN0029

Continuous ICV infusion at one of three dose levels

DRUG

Placebo

Continuous ICV infusion

Trial Locations (1)

University Hospital Leuven, Department of Neurology, Leuven